Skip to main content
. 2021 Nov 10;8:757738. doi: 10.3389/fcvm.2021.757738

Table 1.

Baseline clinical characteristics of controls and chronic inflammatory disease groups in the nested cohort.

Chronic inflammatory disease groups
None HIV Psoriasis RA SSc SLE IBD Multiple CIDs p-value
(n = 10,289) (n = 1,864) (n = 1,759) (n = 995) (n = 153) (n = 371) (n = 1,290) (n = 328)
Age, years (mean ± SD) 50.6 ± 15.6 43.7 ± 10.7 51.5 ± 15.2 57.0 ± 13.8 55.2 ± 14.2 43.7 ± 13.7 47.9 ± 15.9 49.9 ± 13.2 <0.01
Males (%) 44.4 87.4 50.0 18.1 16.3 13.7 44.3 34.0 <0.01
Race/ethnicity (%) <0.01
White 63.4 47.8 74.8 53.0 64.7 33.4 77.9 63.6
Black 13.9 29.2 4.6 23.0 15.0 38.5 9.1 16.7
Hispanic 6.6 9.3 5.7 10.2 11.8 15.1 3.7 7.4
Asian 4.5 1.9 4.5 4.5 3.3 5.7 2.1 1.2
Other 11.6 11.8 10.4 9.3 5.2 7.3 7.2 11.1
Insurance (%) <0.01
Medicaid 4.5 6.8 1.9 4.3 3.3 7.8 1.9 4.3
Medicare 26.3 13.6 24.2 36.7 34.6 25.1 22.2 35.2
Private 51.4 39.1 58.3 45.5 38.6 49.9 59.4 46.9
Self-pay 17.8 40.5 15.6 13.5 23.5 17.3 16.5 13.6
BMI, kg/m3 (mean ± SD) 28.0 ± 6.5 26.5 ± 5.6 29.1 ± 7.0 28.9 ± 7.4 26.2 ± 7.0 28.9 ± 7.6 27.0 ± 6.2 28.2 ± 7.2 <0.01
HTN (%) 21.6 9.4 25.8 31.8 30.7 34.2 17.0 20.4 <0.01
DM (%) 8.6 4.5 10.4 14.9 6.5 6.5 8.9 11.1 <0.01
Smoker (%) 30.1 48.3 35.1 38.7 31.4 28.8 30.1 37.0 <0.01
TC, mg/dL (mean ± SD) 188.5 ± 39.5 173.6 ± 42.1 187.2 ± 38.9 183.9 ± 39.2 174.8 ± 42.3 173.0 ± 43.2 178.0 ± 42.9 185.6 ± 38.4 <0.01
Statin use (%) 23.8 14.2 29.9 36.2 35.3 30.2 20.5 27.8 <0.01
Steroid use (%) 15.6 15.7 21.4 52.9 36.6 62.0 30.7 38.3 <0.01

CID, chronic inflammatory disease; HIV, human immunodeficiency virus; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, systemic sclerosis; IBD, inflammatory bowel disease; SD, standard deviation; BMI, body-mass index; HTN, hypertension; DM, diabetes mellitus; TC, total cholesterol.